Views

CrossRef citations to date

Altmetric

Original Articles

FDG-PET/CT in managing infection in patients with hematological malignancy: clinician knowledge and experience in Australia

Abby P. DouglasDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; Correspondence[email protected]

http://orcid.org/0000-0002-8314-352X

Karin A. ThurskyDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Victorian Infectious Diseases Service, The Peter Doherty Institute for Immunity and Infection, Royal Melbourne Hospital, Melbourne, Australia; ;National Centre for Antimicrobial Stewardship, Melbourne, Australia;

http://orcid.org/0000-0002-7400-232X

Leon J. WorthDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; ;National Centre for Antimicrobial Stewardship, Melbourne, Australia;

http://orcid.org/0000-0003-4304-6845

Simon James HarrisonSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Department of Haematology, Royal Melbourne Hospital, Melbourne, Australia;

http://orcid.org/0000-0003-4555-6582

Rod John HicksSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia

http://orcid.org/0000-0002-0758-0824

Monica A. SlavinDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; ;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; ;Victorian Infectious Diseases Service, The Peter Doherty Institute for Immunity and Infection, Royal Melbourne Hospital, Melbourne, Australia;

http://orcid.org/0000-0002-8443-314X

Abstract

PET/CT is useful for investigation of neutropenic fever (NF) and potential invasive fungal infection (IFI) in those with hematological malignancies (HM). An online survey evaluating the utility and current practices regarding PET/CT scanning for investigation of NF was distributed to infectious diseases (ID) clinicians and hematologists via email lists hosted by key professional bodies. One-hundred and forty-five clinicians responded (120 ID; 25 hematologists). Access to PET/CT was fair but timeliness of investigation was limited (within 3 days in 35% and 46% of ID and hematology respondents, respectively). Among those with experience with PET/CT for infection (n = 109), 40% had utilized PET/CT for prolonged NF and 20% for diagnosing IFI. The majority of respondents indicated the desire to utilize PET/CT more frequently for infection indications. There is a strong desire among surveyed Australian clinicians to use PET/CT for prolonged NF and potential IFI. However, access to PET/CT is a current barrier to uptake.

Keywords:

Acknowledgments

We thank Professor Sharon Chen, and Dr Alan Street and Dr Louise Cooley for their contributions to the survey. We also thank the Australasian Leukemia and Lymphoma Group and the Haematology Society of Australia and New Zealand for their kind distribution of the survey.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2019.1590571.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

FDG-PET/CT in managing infection in patients with hematological malignancy: clinician knowledge and experience in Australia

Information for

Open access

Opportunities

Help and information

FDG-PET/CT in managing infection in patients with hematological malignancy: clinician knowledge and experience in Australia

Abstract

Acknowledgments

Potential conflict of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature